Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Shepherd

Showing results (1111-1120 of 1,281) with videos related to

Pageof 129
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 25, 2011
Treatment of the elderly when cure is the goal: the influence of age on treatment selection and efficacy for stage III non-small cell lung cancerLinda E Coate, Christine Massey, Andrew Hope, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2006
Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21Andrea Bezjak, Dongsheng Tu, Lesley Seymour, et al.
European Journal of Cancer (Oxford, England : 1990)|March 16, 2013
Phase I-IIa study of BMS-690514, an EGFR, HER-2 and -4 and VEGFR-1 to -3 oral tyrosine kinase inhibitor, in patients with advanced or metastatic solid tumoursJean-Charles Soria, José Baselga, Nasser Hanna, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 21, 2014
Comparison of mammographic density assessed as volumes and areas among women undergoing diagnostic image-guided breast biopsyGretchen L Gierach, Berta M Geller, John A Shepherd, et al.
Obesity (Silver Spring, Md.)|September 22, 2021
A pose-independent method for accurate and precise body composition from 3D optical scansMichael C Wong, Bennett K Ng, Isaac Tian, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 2, 2017
Treatment options for patients with brain metastases from EGFR/ALK-driven lung cancerMark K Doherty, Grzegorz J Korpanty, Pascale Tomasini, et al.
Virchows Archiv : an International Journal of Pathology|February 4, 2014
The histopathological approach to inflammatory bowel disease: a practice guideCord Langner, Fernando Magro, Ann Driessen, et al.
The Annals of Thoracic Surgery|July 30, 2014
Long-term outcome after resection of non-small cell lung cancer invading the thoracic inletStéphane Collaud, Tiago Machuca, Olaf Mercier, et al.
Clinical Lung Cancer|October 21, 2022
Real-World Treatment Sequencing, Toxicities, Health Utilities, and Survival Outcomes in Patients with Advanced ALK-Rearranged Non-Small-Cell Lung CancerSabine Schmid, Sierra Cheng, Simren Chotai, et al.
Nature Communications|February 27, 2023
Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer from the AURA3 trialJuliann Chmielecki, Tony Mok, Yi-Long Wu, et al.
Pageof 129

Showing results (1111-1120 of 1,281) with videos related to

Sort By:
Pageof 129
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 25, 2011
Treatment of the elderly when cure is the goal: the influence of age on treatment selection and efficacy for stage III non-small cell lung cancerLinda E Coate, Christine Massey, Andrew Hope, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 22, 2006
Symptom improvement in lung cancer patients treated with erlotinib: quality of life analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21Andrea Bezjak, Dongsheng Tu, Lesley Seymour, et al.
European Journal of Cancer (Oxford, England : 1990)|March 16, 2013
Phase I-IIa study of BMS-690514, an EGFR, HER-2 and -4 and VEGFR-1 to -3 oral tyrosine kinase inhibitor, in patients with advanced or metastatic solid tumoursJean-Charles Soria, José Baselga, Nasser Hanna, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 21, 2014
Comparison of mammographic density assessed as volumes and areas among women undergoing diagnostic image-guided breast biopsyGretchen L Gierach, Berta M Geller, John A Shepherd, et al.
Obesity (Silver Spring, Md.)|September 22, 2021
A pose-independent method for accurate and precise body composition from 3D optical scansMichael C Wong, Bennett K Ng, Isaac Tian, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 2, 2017
Treatment options for patients with brain metastases from EGFR/ALK-driven lung cancerMark K Doherty, Grzegorz J Korpanty, Pascale Tomasini, et al.
Virchows Archiv : an International Journal of Pathology|February 4, 2014
The histopathological approach to inflammatory bowel disease: a practice guideCord Langner, Fernando Magro, Ann Driessen, et al.
The Annals of Thoracic Surgery|July 30, 2014
Long-term outcome after resection of non-small cell lung cancer invading the thoracic inletStéphane Collaud, Tiago Machuca, Olaf Mercier, et al.
Clinical Lung Cancer|October 21, 2022
Real-World Treatment Sequencing, Toxicities, Health Utilities, and Survival Outcomes in Patients with Advanced ALK-Rearranged Non-Small-Cell Lung CancerSabine Schmid, Sierra Cheng, Simren Chotai, et al.
Nature Communications|February 27, 2023
Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer from the AURA3 trialJuliann Chmielecki, Tony Mok, Yi-Long Wu, et al.
Pageof 129